Final results from the ZENITH-1 study: Oral administration of plasma kallikrein inhibitor BCX7353 for the treatment of attacks in patients with hereditary angioedema

H. J. Longhurst; M. Stobiecki; A. Zanichelli; A. Huissoon; D. Moldovan; M. Maurer; M. Magerl; M. Cancian; R. Senter; A. Manson; E. Aygoeren-Puersuen; V Grivcheva-Panovska; D. Hagin; U. Steiner; S. Kiani-Alikhan; N. Agmon-Levin; A. Bygum; W. Aberer; S. N. Faust; D. Launay; M. Gompels; M. Triggiani; C. Bethune; A. Reshef; M. Cornpropst; S. Dobo; S. Van Dyke; S. Murray; P. Collis; W. P. Sheridan; H. Farkas; M. Cicardi

Final results from the ZENITH-1 study: Oral administration of plasma kallikrein inhibitor BCX7353 for the treatment of attacks in patients with hereditary angioedema

H. J. Longhurst, M. Stobiecki, A. Zanichelli, A. Huissoon, D. Moldovan, M. Maurer, M. Magerl, M. Cancian, R. Senter, A. Manson, E. Aygoeren-Puersuen, V Grivcheva-Panovska, D. Hagin, U. Steiner, S. Kiani-Alikhan, N. Agmon-Levin, A. Bygum, W. Aberer, S. N. Faust, D. LaunayM. Gompels, M. Triggiani, C. Bethune, A. Reshef, M. Cornpropst, S. Dobo, S. Van Dyke, S. Murray, P. Collis, W. P. Sheridan, H. Farkas, M. Cicardi

KI, OUH, Forskningsenhed for Dermatovenerologi og allergi (Odense)

Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › peer review

Originalsprog	Engelsk
Tidsskrift	Allergy
Vol/bind	74
Udgave nummer	Suppl. 106
Sider (fra-til)	10-11
Antal sider	2
ISSN	0105-4538
Status	Udgivet - 1. aug. 2019
Begivenhed	European Academy of Allergy and Clinical Immunology Congress 2019 - Lisbon, Portugal Varighed: 1. jun. 2019 → 5. jun. 2019

Konference

Konference	European Academy of Allergy and Clinical Immunology Congress 2019
Land/Område	Portugal
By	Lisbon
Periode	01/06/2019 → 05/06/2019

Bibliografisk note

Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI), Lisbon, PORTUGAL, JUN 01-05, 2019

SDU link

Tjek adgangen til materialet i Syddansk Universitetsbiblioteks søgemaskine

Citationsformater

Longhurst, H. J., Stobiecki, M., Zanichelli, A., Huissoon, A., Moldovan, D., Maurer, M., Magerl, M., Cancian, M., Senter, R., Manson, A., Aygoeren-Puersuen, E., Grivcheva-Panovska, V., Hagin, D., Steiner, U., Kiani-Alikhan, S., Agmon-Levin, N., Bygum, A., Aberer, W., Faust, S. N., ... Cicardi, M. (2019). Final results from the ZENITH-1 study: Oral administration of plasma kallikrein inhibitor BCX7353 for the treatment of attacks in patients with hereditary angioedema. Allergy, 74(Suppl. 106), 10-11.

@article{5939e6148d62470da8f163d08fa9c7e8,

title = "Final results from the ZENITH-1 study: Oral administration of plasma kallikrein inhibitor BCX7353 for the treatment of attacks in patients with hereditary angioedema",

author = "Longhurst, {H. J.} and M. Stobiecki and A. Zanichelli and A. Huissoon and D. Moldovan and M. Maurer and M. Magerl and M. Cancian and R. Senter and A. Manson and E. Aygoeren-Puersuen and V Grivcheva-Panovska and D. Hagin and U. Steiner and S. Kiani-Alikhan and N. Agmon-Levin and A. Bygum and W. Aberer and Faust, {S. N.} and D. Launay and M. Gompels and M. Triggiani and C. Bethune and A. Reshef and M. Cornpropst and S. Dobo and {Van Dyke}, S. and S. Murray and P. Collis and Sheridan, {W. P.} and H. Farkas and M. Cicardi",

note = "Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI), Lisbon, PORTUGAL, JUN 01-05, 2019; European Academy of Allergy and Clinical Immunology Congress 2019 ; Conference date: 01-06-2019 Through 05-06-2019",

year = "2019",

month = aug,

day = "1",

language = "English",

volume = "74",

pages = "10--11",

journal = "Allergy",

issn = "0105-4538",

publisher = "Wiley",

number = "Suppl. 106",

}

Longhurst, HJ, Stobiecki, M, Zanichelli, A, Huissoon, A, Moldovan, D, Maurer, M, Magerl, M, Cancian, M, Senter, R, Manson, A, Aygoeren-Puersuen, E, Grivcheva-Panovska, V, Hagin, D, Steiner, U, Kiani-Alikhan, S, Agmon-Levin, N, Bygum, A, Aberer, W, Faust, SN, Launay, D, Gompels, M, Triggiani, M, Bethune, C, Reshef, A, Cornpropst, M, Dobo, S, Van Dyke, S, Murray, S, Collis, P, Sheridan, WP, Farkas, H & Cicardi, M 2019, 'Final results from the ZENITH-1 study: Oral administration of plasma kallikrein inhibitor BCX7353 for the treatment of attacks in patients with hereditary angioedema', Allergy, bind 74, nr. Suppl. 106, s. 10-11.

Final results from the ZENITH-1 study: Oral administration of plasma kallikrein inhibitor BCX7353 for the treatment of attacks in patients with hereditary angioedema. / Longhurst, H. J.; Stobiecki, M.; Zanichelli, A. et al.
I: Allergy, Bind 74, Nr. Suppl. 106, 01.08.2019, s. 10-11.

Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › peer review

TY - ABST

T1 - Final results from the ZENITH-1 study: Oral administration of plasma kallikrein inhibitor BCX7353 for the treatment of attacks in patients with hereditary angioedema

AU - Longhurst, H. J.

AU - Stobiecki, M.

AU - Zanichelli, A.

AU - Huissoon, A.

AU - Moldovan, D.

AU - Maurer, M.

AU - Magerl, M.

AU - Cancian, M.

AU - Senter, R.

AU - Manson, A.

AU - Aygoeren-Puersuen, E.

AU - Grivcheva-Panovska, V

AU - Hagin, D.

AU - Steiner, U.

AU - Kiani-Alikhan, S.

AU - Agmon-Levin, N.

AU - Bygum, A.

AU - Aberer, W.

AU - Faust, S. N.

AU - Launay, D.

AU - Gompels, M.

AU - Triggiani, M.

AU - Bethune, C.

AU - Reshef, A.

AU - Cornpropst, M.

AU - Dobo, S.

AU - Van Dyke, S.

AU - Murray, S.

AU - Collis, P.

AU - Sheridan, W. P.

AU - Farkas, H.

AU - Cicardi, M.

N1 - Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI), Lisbon, PORTUGAL, JUN 01-05, 2019

PY - 2019/8/1

Y1 - 2019/8/1

M3 - Conference abstract in journal

SN - 0105-4538

VL - 74

SP - 10

EP - 11

JO - Allergy

JF - Allergy

IS - Suppl. 106

T2 - European Academy of Allergy and Clinical Immunology Congress 2019

Y2 - 1 June 2019 through 5 June 2019

ER -